Search
  • Aundrea Foster

Legislators call out DEA for not reflecting the intentions of Congress in its proposed hemp rules


Last August, the U.S. Drug Enforcement Administration (DEA) released an Interim Final Rule for hemp. It is a different set of regulations from the Interim Final Rule and Final Rule released by the United States Department of Agriculture (USDA). This difference is reportedly causing some confusion in the hemp industry, and two legislators have recently voiced concerns over what they suggest is a DEA overreach.


Two U.S. House committee chairmen recently sent a letter to U.S. Attorney General Merrick Garland and Department of Agriculture Secretary Thomas Vilsack. In the letter, the chairmen expressed their “concern over the serious unintended consequences that could arise from the [DEA’s] Interim Final Rule.”


The chairmen also urged the DEA and USDA to work with hemp industry stakeholders to “resolve concerns with the DEA’s regulations.” House Agriculture Committee Chairman David Scott and House Appropriations Subcommittee on Agriculture Chairman Sanford Bishop signed the letter, which was sent on March 29.


What is the problem with the DEA’s Interim Final Rule for hemp?


According to Marijuana Moment, the DEA claims that its proposed regulations were intended to make its procedures compliant with federal law. However, the article indicates that many hemp industry professionals feel that the purpose of the DEA’s regulations was actually to empower the agency to take enforcement actions in the newly legal hemp industry.


One specific concern revolves around the belief that the DEA’s proposed regulations would criminalize certain unfinished hemp products.


The 2018 Farm Bill defines hemp as cannabis plants that contain no more than 0.3 percent Delta-9-THC. However, the industry is reportedly concerned that the DEA’s rule could allow the agency to take enforcement action during a stage in the manufacturing process for extracts when the hemp-derived product temporarily exceeds that limit. These unfinished extracts may temporarily exceed the limit even though they are being made from legally compliant hemp and being made into legally compliant finished products.


How did Congress intend for hemp to be regulated?


The letter sent on behalf of Scott and Bishop suggests that these proposed regulations are not in agreement with the intentions Congress had when it passed the 2018 Farm Bill. The letter clarifies that Congress intended for the USDA to be the entity that controls hemp regulations — not the DEA.


“When Congress passed the 2018 Farm Bill, it was our intent to vest primary regulatory authority over the production of hemp with the USDA,” the letter states. “Congress did not intend the 2018 Farm Bill to criminalize any stage of legal hemp processing, and we are concerned that hemp grown in compliance with a USDA-approved plan could receive undue scrutiny from the DEA as it is being processed into a legal consumer-facing product under this IFR.”


“In addition to the economic impacts, we are concerned that the lack of a uniform, risk appropriate Federal regulatory approach will stifle innovation, advancement, and product development in an industry poised for robust growth in the coming years,” the letter adds.


What will happen next?


The USDA issued its Final Rule on Hemp in January, and that set of regulations went into effect March 22 after a review by the Biden administration. The letter explains that the USDA’s review of hemp regulations makes this an appropriate time to make sure that there is consistency across federal agencies.


The letter also requests that the DEA and USDA meet with industry stakeholders to remedy the problem. It specifically asks for the entities to “resolve issues raised by the [DEA’s Interim Final Rule], and to clarify publicly that the USDA is the primary Federal agency in charge of regulating the transportation, processing, sale, or use of hemp and in-process hemp extract.”


“As leaders on agriculture policy in the U.S. House of Representatives, it is our underlying goal to ensure that Federal regulations concerning hemp are fair, easily understood, and consistent across agencies,” Scott and Bishop said in their letter. “We believe that stronger collaboration between USDA, DOJ, other Federal agencies, and hemp industry stakeholders could help alleviate many issues impacting our hemp producers.”


Source


[1] https://www.marijuanamoment.net/deas-proposed-hemp-rules-are-contrary-to-intent-of-congress-committee-chairs-say/

214 views0 comments

 LOCATIONS

SAINT PAUL 

844 Grand Ave Saint Paul MN

55105

Orlando | Dixie Bell

948 S Sermon Blvd 

Orlando Florida 32807

MAPLEWOOD MALL  

 (moved location 3 miles downtown White Bear Lake)

3001 White Bear Ave  Maplewood, MN 55109

©2020 by Nothing But Hemp. Proudly created by SocialThis, LLC

 

Nothing But Hemp offers CBD oil in Minneapolis and the surrounding cities. CBD Oil Products is not for use by or sale to persons under the age of 18. This product should be used only as directed on the label. It should not be used if you are pregnant or nursing. Consult with a physician before use if you have a serious medical condition or use prescription medications. A Doctor's advice should be sought before using this and any supplemental dietary product. All trademarks and copyrights are property of their respective owners and are not affiliated with nor do they endorse this product. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. These products contain up to .03% THC. Individual weight loss results will vary. Contact Support for return policy.

The Nothing But Hemp, LLC shall not be held liable for the medical claims made by customer testimonials. The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products and the testimonials made have not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners and legal professionals. Please consult your healthcare professional about potential interactions or other possible complications before using any product. Please consult your own legal counsel to determine whether your purchase and intended use are legal in your state.

 

The Federal Food, Drug, and Cosmetic Act requires this notice.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease or ailment.

 

The Nothing But Hemp, LLC assumes no responsibility for the improper use of these products. We recommend consulting with a qualified medical doctor or physician when preparing a treatment plan for any and all diseases or ailments.

 

The Nothing But Hemp, LLC not make any health claims about our products and recommend consulting with a qualified medical doctor or physician prior to consuming our products or preparing a treatment plan. It is especially important for those who are pregnant, nursing, chronically ill, elderly or under the age of 18 to discuss the use of these products with a physician prior to consuming.  You must be 18 years or older to visit this website and/or purchase Nothing But Hemp, LLC  products. 

 

The information on our website is intended to provide general information regarding our products and is not to be construed as medical advice or instruction.

18K.02 DEFINITIONS.

Subd. 3.Industrial hemp. “Industrial hemp” means the plant Cannabis sativa L. and any part of the plant, whether growing or not, including the plant’s seeds, and all the plant’s derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis. Industrial hemp is not marijuana as defined in section 152.01, subdivision 9.